Organization
Clermont Oncology Center, Clermont, FL
1 abstract
Abstract
A phase 2/3 study of fianlimab, cemiplimab, plus chemotherapy versus cemiplimab plus chemotherapy in first-line treatment of advanced non-small cell lung cancer.Org: High Technology Medical Center, University Clinic Ltd., Tbilisi, Georgia, LTD High Technology Hospital Med Center, Batumi, Georgia, JSC Vian Caraps Medline, European University, Tbilisi, Georgia, University of Tennessee Medical Center, Knoxville, TN, Mid Florida Cancer Centers, Orange City, FL,